Trade Grifols, S.A. - GRLS CFD
Add to favourite- Summary
- Historical Data
Spread | 0.07 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.017952% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.004271% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | EUR | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | Spain | ||||||||
Commission on trade | 0% |
Prev. Close | 8.18 |
Open | 8.26 |
1-Year Change | -0.48% |
Day's Range | 8.04 - 8.35 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 31, 2025 | 8.18 | -0.33 | -3.88% | 8.51 | 8.51 | 8.11 |
Mar 28, 2025 | 8.54 | -0.15 | -1.73% | 8.69 | 8.75 | 8.53 |
Mar 27, 2025 | 8.62 | -0.28 | -3.15% | 8.90 | 8.90 | 8.60 |
Mar 26, 2025 | 8.89 | -0.16 | -1.77% | 9.05 | 9.05 | 8.82 |
Mar 25, 2025 | 9.10 | -0.11 | -1.19% | 9.21 | 9.23 | 9.06 |
Mar 24, 2025 | 9.15 | -0.10 | -1.08% | 9.25 | 9.25 | 9.11 |
Mar 21, 2025 | 9.19 | -0.11 | -1.18% | 9.30 | 9.35 | 9.14 |
Mar 20, 2025 | 9.35 | -0.26 | -2.71% | 9.61 | 9.72 | 9.33 |
Mar 19, 2025 | 9.57 | -0.01 | -0.10% | 9.58 | 9.65 | 9.50 |
Mar 18, 2025 | 9.61 | 0.06 | 0.63% | 9.55 | 9.74 | 9.53 |
Mar 17, 2025 | 9.49 | 0.04 | 0.42% | 9.45 | 9.56 | 9.41 |
Mar 14, 2025 | 9.40 | 0.15 | 1.62% | 9.25 | 9.49 | 9.21 |
Mar 13, 2025 | 9.25 | -0.04 | -0.43% | 9.29 | 9.39 | 9.17 |
Mar 12, 2025 | 9.35 | -0.14 | -1.48% | 9.49 | 9.59 | 9.08 |
Mar 11, 2025 | 9.36 | -0.58 | -5.84% | 9.94 | 9.98 | 9.19 |
Mar 10, 2025 | 9.98 | -0.31 | -3.01% | 10.29 | 10.35 | 9.81 |
Mar 7, 2025 | 10.35 | -0.09 | -0.86% | 10.44 | 10.59 | 10.33 |
Mar 6, 2025 | 10.62 | -0.37 | -3.37% | 10.99 | 11.04 | 10.52 |
Mar 5, 2025 | 10.92 | 0.01 | 0.09% | 10.91 | 11.23 | 10.86 |
Mar 4, 2025 | 10.70 | -0.23 | -2.10% | 10.93 | 11.02 | 10.61 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Grifols Company profile
About Grifols SA
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Grifols SA revenues decreased 8% to EUR4.93B. Net income before extraordinary items decreased 72% to EUR182.8M. Revenues reflect Bioscience segment decrease of 10% to EUR3.81B, United States/Canada segment decrease of 12% to EUR3.15B, Rest of the World segment decrease of 4% to EUR872.1M. Net income also reflects Selling/General/Admin. Expense - Balanci increase of 11% to EUR567.3M (expense).
Equity composition
12/11, 10% Stock dividend. 12/2011, Scrip Issue, 1 new share for every 10 shares held @ EUR0.1 (Factor: 1.1), 12/2012, Scrip Issue, 1 new B shares for every 20 B shares held (Factor: 1.05). 1/2016, 2-for-1 stock split (Factor: 2).
Industry: | Biopharmaceuticals |
C/ Jesús y María, 6
BARCELONA
BARCELONA 08022
ES
News

Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com